U.S. federal trademark · Serial No. 75372070 · Reg. No. 2339601
bio-engineered cellular material which is a component of pharmaceutical and therapeutic preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, hematologic diseases, immune diseases and hormone deficiencies, namely, a packaging cell line that produces retroviral gene therapy vectors
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.